Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 982.29 USD 1.48% Market Closed
Updated: May 18, 2024

Regeneron Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Regeneron Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
MRNA
VRTX

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Moderna Inc
NASDAQ:MRNA
Gross Profit
$1.2B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.8B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
26%

See Also

What is Regeneron Pharmaceuticals Inc's Gross Profit?
Gross Profit
11.3B USD

Based on the financial report for Mar 31, 2024, Regeneron Pharmaceuticals Inc's Gross Profit amounts to 11.3B USD.

What is Regeneron Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
18%

Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for Regeneron Pharmaceuticals Inc have been 12% over the past three years , 13% over the past five years , and 18% over the past ten years .